StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.23+0.01 (+0.82%)

Close on Nov 18, 2026Market cap $27.88MP/E –Yield –

BioHarvest Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $34.51M, up 37.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$34.51M+37.0%
FY2024Dec 31, 2024$25.19M+98.8%
FY2023Dec 31, 2023$12.67M–

More BioHarvest Sciences figures

See a number that looks wrong?